Since joining Putnam in 2017, Ethan has advised clients on a variety of business needs including pricing and market access strategy, commercial opportunity assessment, competitor strategic simulation, operational model development, and supply and demand forecasting.
A core focus of Ethan’s work has been within the Value, Pricing & Access strategy practice area, where he has supported global pharmaceutical and biotech clients across both US and international markets. Ethan has extensive experience in developing access strategies at all stages of the product lifecycle, from launch access strategy through loss of exclusivity strategy. He has covered a broad range of therapeutic areas, with a particular focus on inflammation and immunology, rare disease (in particular, hematologic and cardiac), vaccines, and oncology (in particular, cell therapy).
Before Putnam, Ethan earned a B.S. in Biology and B.A. in Economics from Boston College.